Last reviewed · How we verify
Glimid (GLUTETHIMIDE)
At a glance
| Generic name | GLUTETHIMIDE |
|---|---|
| Sponsor | Sandoz |
| Target | GABA-A receptor alpha-1/beta-3/gamma-2 |
| Modality | Small molecule |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
| First approval | 1976 |
Approved indications
- Insomnia
Common side effects
Key clinical trials
- Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients (PHASE3)
- A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |